Can Pneumothorax Developing in COVID-19 Patients be a Mortality Marker?
| dc.contributor.author | OTERKUS, MESUT | |
| dc.contributor.author | Delen, Leman Acun | |
| dc.contributor.author | Kasapoglu, Umut Sabri | |
| dc.date.accessioned | 2025-10-24T18:03:25Z | |
| dc.date.available | 2025-10-24T18:03:25Z | |
| dc.date.issued | 2022 | |
| dc.department | Malatya Turgut Özal Üniversitesi | |
| dc.description.abstract | Objectives: The purpose of this study is to investigate the effects of pneumothorax (PX), a rare complication of COVID-19, on mortality. Methods: All patients admitted to our hospital with the diagnosis of COVID-19 were screened, and patients who developed PX were includ- ed in the study. Patient demographics data, number of days of hospital- ization for comorbidities, day and duration of thorax tube insertion, and laboratory findings during hospitalization were recorded by scanning the hospital automation system and patient records. Results: For our study, 7485 patients hospitalized with the diagno- sis of COVID-19 were screened in intensive care unit. PX was de - tected in 32 (0.296%) of the patients. About 59.4% of these patients included in the study were male. DM was the most common co - morbid condition at 56.3%. In these patients, the mortality rate was found to be 90.6%. Conclusion: The data obtained indicate that PX, a COVID-19 complica- tion, leads to a serious increase in mortality. We believe that using pro- tective ventilation methods to avoid the development of pneumotarax will help to reduce mortality. | |
| dc.identifier.doi | 10.14744/GKDAD.2021.50455 | |
| dc.identifier.endpage | 361 | |
| dc.identifier.issn | 2548-0669 | |
| dc.identifier.issue | 4 | |
| dc.identifier.startpage | 357 | |
| dc.identifier.trdizinid | 1166505 | |
| dc.identifier.uri | https://doi.org/10.14744/GKDAD.2021.50455 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1166505 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12899/2217 | |
| dc.identifier.volume | 28 | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.language.iso | en | |
| dc.relation.ispartof | Göğüs Kalp Damar Anestezi ve Yoğun Bakım Derneği Dergisi | |
| dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | TR-Dizin_20251023 | |
| dc.subject | Solunum Sistemi | |
| dc.subject | Sağlık Politikaları ve Hizmetleri | |
| dc.subject | Acil Tıp | |
| dc.subject | Temel Sağlık Hizmetleri | |
| dc.subject | Yoğun Bakım | |
| dc.subject | Tıp | |
| dc.title | Can Pneumothorax Developing in COVID-19 Patients be a Mortality Marker? | |
| dc.type | Article |
